Report cover image

Veterinary Oncology Market Growth, Size, Trends Analysis- By Animal Type, By Therapy, By Cancer Type - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published May 28, 2025
Length 255 Pages
SKU # SPER20187051

Description

Veterinary Oncology Market Introduction and Overview

According to SPER market research, ‘Global Veterinary Oncology Market Size- By Animal Type, By Therapy, By Cancer Type – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Veterinary Oncology Market is predicted to reach 5.04 Billion by 2034 with a CAGR 12.36%.

Veterinary oncology is a specialized area of veterinary medicine dedicated to the diagnosis, treatment, and management of cancer in animals. It involves a range of treatment options, including surgery, chemotherapy, radiation, and newer therapies like immunotherapy and targeted treatments. Given that cancer is a major cause of illness and death in companion animals, especially older pets, veterinary oncology is essential for enhancing their quality of life and extending their longevity.

Restraints:

The veterinary oncology market faces several challenges that can hinder its growth and accessibility. A major issue is the high cost of cancer treatments, which can be unaffordable for many pet owners, restricting access to essential care. Moreover, there is a shortage of specialized veterinary oncologists and a limited number of advanced treatment centers, especially in rural areas, making it challenging for pet owners to find expert care.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered

By Animal Type, By Therapy, By Cancer Type

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Elanco, Boehringer Ingelheim International GmbH, Zoetis, Elekta AB, PetCure Oncology, Accuray Incorporated, Varian Medical Systems, Inc. (parent company: Siemens Healthineers), Virbac, Merck & Co., Inc., Ardent Animal Health, LLC.

Global Veterinary Oncology Market Segmentation:

By Animal Type: Based on the Animal Type, Global Veterinary Oncology Market is segmented as; Canine, Feline, Equine.

By Therapy: Based on the Therapy, Global Veterinary Oncology Market is segmented as; Radiotherapy, Surgery, Chemotherapy, Immunotherapy, Other Therapies.

By Cancer Type: Based on the Cancer Type, Global Veterinary Oncology Market is segmented as; Skin Cancers, Lymphomas, Sarcomas, Others.

By Region:

This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Table of Contents

255 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Veterinary Oncology Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Veterinary Oncology Market
7. Global Veterinary Oncology Market, By Animal Type, (USD Million) 2021-2034
7.1. Canine
7.2. Feline
7.3. Equine
8. Global Veterinary Oncology Market, By Therapy, (USD Million) 2021-2034
8.1. Radiotherapy
8.1.1. Stereotactic Radiation Therapy
8.1.2. Conventional Radiation Therapy
8.2. Surgery
8.3. Chemotherapy
8.4. Immunotherapy
8.5. Other Therapies
9. Global Veterinary Oncology Market, By Cancer Type, (USD Million) 2021-2034
9.1. Skin Cancers
9.2. Lymphomas
9.3. Sarcomas
9.4. Others
10. Global Veterinary Oncology Market, (USD Million) 2021-2034
10.1. Global Veterinary Oncology Market Size and Market Share
11. Global Veterinary Oncology Market, By Region, 2021-2034 (USD Million)
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Elanco
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Boehringer Ingelheim International GmbH
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Zoetis
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Elekta AB
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. PetCure Oncology
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Accuray Incorporated
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Varian Medical Systems, Inc. (parent company: Siemens Healthineers)
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Virbac
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Merck & Co., Inc.
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Ardent Animal Health, LLC
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us